Jesper Pallesen

Jesper Pallesen

Auto-generated profile, based on publicly available information

Jesper Pallesen

The Wistar Institute

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JPJesper Pallesen
Jesper Pallesen
NWNianshuang Wang
Nianshuang Wang
KCKizzmekia S. Corbett
Kizzmekia S. Corbett
DWDaniel Wrapp
Daniel Wrapp
RKRobert N. Kirchdoerfer
Robert N. Kirchdoerfer
JMJason McLellan
Jason McLellan
Significance: Coronaviruses such as Middle East respiratory syndrome coronavirus (MERS-CoV) cause severe respiratory distress with high fatality rates. The spike (S) glycoprotein is a determinant of host range and is the target of neutralizing antibodies and subunit vaccine development. We describe an engineering strategy for stabilization of soluble S proteins in the prefusion conformation, which results in greatly increased expression, conformational homogeneity, and elicitation of potent antibody responses. Cryo-EM structures of the stabilized MERS-CoV S protein in complex with a stem-directed neutralizing antibody provide a molecular basis for host-cell protease requirements and identify a site of immune pressure. We also defined four conformational states of the trimer wherein each receptor-binding domain is either packed together at the membrane-distal apex or rotated into a receptor-accessible conformation.

2 March 2016 in Nature
Verified
Journal Article
Closed access
PDF file
RKRobert N. Kirchdoerfer
Robert N. Kirchdoerfer
CCChristopher A. Cottrell
Christopher A. Cottrell
NWNianshuang Wang
Nianshuang Wang
JPJesper Pallesen
Jesper Pallesen
HYHadi M. Yassine
Hadi M. Yassine
AWAndrew Ward
Andrew Ward

24 October 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RKRobert N. Kirchdoerfer
Robert N. Kirchdoerfer
NWNianshuang Wang
Nianshuang Wang
JPJesper Pallesen
Jesper Pallesen
DWDaniel Wrapp
Daniel Wrapp
HTHannah L. Turner
Hannah L. Turner
AWAndrew Ward
Andrew Ward
Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in 2002 as a highly transmissible pathogenic human betacoronavirus. The viral spike glycoprotein (S) utilizes angiotensin-converting enzyme 2 (ACE2) as a host protein receptor and mediates fusion of the viral and host membranes, making S essential to viral entry into host cells and host species tropism. As SARS-CoV enters host cells, the viral S is believed to undergo a number of conformational transitions as it is cleaved by host proteases and binds to host receptors. We recently developed stabilizing mutations for coronavirus spikes that prevent the transition from the pre-fusion to post-fusion states. Here, we present cryo-EM analyses of a stabilized trimeric SARS-CoV S, as well as the trypsin-cleaved, stabilized S, and its interactions with ACE2. Neither binding to ACE2 nor cleavage by trypsin at the S1/S2 cleavage site impart large conformational changes within stabilized SARS-CoV S or expose the secondary cleavage site, S2′.

12 July 2017 in Nature
Verified
Journal Article
Open access
PDF file
GOGabriel Ozorowski
Gabriel Ozorowski
JPJesper Pallesen
Jesper Pallesen
NVNatalia de Val
Natalia de Val
DLDmitry Lyumkis
Dmitry Lyumkis
CCChristopher A. Cottrell
Christopher A. Cottrell
AWAndrew Ward
Andrew Ward
New high-resolution cryo-electron microscopy structures of the HIV-1 envelope protein provide a detailed description and understanding of how the HIV-1 fusion machinery functions and how it changes its structure over time to convert from the pre-fusion to the fusion-intermediate conformation. The envelope glycoprotein on the surface of HIV (Env) binds to its cellular receptor CD4 and co-receptor CXCR4/CCR5. Upon receptor binding it undergoes structural rearrangements that result in fusion between the lipid bilayer of the virus and the host cell membrane. Several previous studies have revealed static pre-fusion, intermediate and post-fusion states of HIV-1 Env. In this study, Andrew Ward and colleagues present a variety of new high resolution cryo-electron microscopy structures of Env, which together provide a detailed description and understanding of how the HIV-1 fusion machinery functions and how it changes its structure over time to convert from the pre- to the post-fusion confirmation. For many enveloped viruses, binding to a receptor(s) on a host cell acts as the first step in a series of events culminating in fusion with the host cell membrane and transfer of genetic material for replication1,2. The envelope glycoprotein (Env) trimer on the surface of HIV is responsible for receptor binding and fusion. Although Env can tolerate a high degree of mutation in five variable regions (V1–V5), and also at N-linked glycosylation sites that contribute roughly half the mass of Env, the functional sites for recognition of receptor CD4 and co-receptor CXCR4/CCR5 are conserved and essential for viral fitness. Soluble SOSIP Env trimers are structural and antigenic mimics of the pre-fusion native, surface-presented Env3,4, and are targets of broadly neutralizing antibodies. Thus, they are attractive immunogens for vaccine development5,6,7,8. Here we present high-resolution cryo-electron microscopy structures of subtype B B41 SOSIP Env trimers in complex with CD4 and antibody 17b, or with antibody b12, at resolutions of 3.7 Å and 3.6 Å, respectively. We compare these to cryo-electron microscopy reconstructions of B41 SOSIP Env trimers with no ligand or in complex with either CD4 or the CD4-binding-site antibody PGV04 at 5.6 Å, 5.2 Å and 7.4 Å resolution, respectively. Consequently, we present the most complete description yet, to our knowledge, of the CD4–17b-induced intermediate and provide the molecular basis of the receptor-binding-induced conformational change required for HIV-1 entry into host cells. Both CD4 and b12 induce large, previously uncharacterized conformational rearrangements in the gp41 subunits, and the fusion peptide becomes buried in a newly formed pocket. These structures provide key details on the biological function of the type I viral fusion machine from HIV-1 as well as new templates for inhibitor design.

24 November 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ADAli Dashti
Ali Dashti
PSPeter Schwander
Peter Schwander
RLRobert Langlois
Robert Langlois
RFRussell Fung
Russell Fung
WLWen Li
Wen Li
AOAbbas Ourmazd
Abbas Ourmazd
Significance: Many functions in the cell are performed by Brownian machines, macromolecular assemblies that use energy from the thermal environment for many of the conformational changes involved in their work cycles. Here we present a new approach capable of mapping the continuous motions of such nanomachines along their trajectories in the free-energy landscape and demonstrate this capability in the context of experimental cryogenic electron microscope snapshots of the ribosome, the nanomachine responsible for protein synthesis in all living organisms. We believe our approach constitutes a universal platform for the analysis of free-energy landscapes and conformational motions of molecular nanomachines and their dependencies on temperature, buffer conditions, and regulatory factors.

2 November 2018 in Science
Verified
Journal Article
Closed access
PDF file
NLNick Stub Laursen
Nick Stub Laursen
RFRobert H. E. Friesen
Robert H. E. Friesen
XZXueyong Zhu
Xueyong Zhu
MJMandy Jongeneelen
Mandy Jongeneelen
SBSven Blokland
Sven Blokland
IWIan A. Wilson
Ian A. Wilson
Durable influenza protection: Vaccines are indispensable for the control and prevention of influenza, but there are several challenges to efficacy. Some individuals respond poorly to vaccination, and virus variation makes targeting optimal antigens difficult. Broadly neutralizing antibodies are one solution, but they have their own pitfalls, including limited cross-reactivity to both influenza A and B strains and the need for repeated injections. Now, Laursen et al. have developed multidomain antibodies with breadth and potency. Administered intranasally to mice with an adeno-associated virus vector, the antibodies provided durable and continuous protection from a panoply of influenza strains. Science , this issue p. 598